Korean J Pathol.  2010 Dec;44(6):642-650.

IMP3 Expression of the Cholangiocarcinoma in Cytology Specimen and Its Diagnostic Value

Affiliations
  • 1Department of Pathology, Gyeongsang National University School of Medicine, Jinju, Korea. jhlee7@gnu.ac.kr

Abstract

BACKGROUND
Pathologists occasionally have difficulty in distinguishing cholangiocarcinoma from benign reactive cells on the biliary cytology. We estimated the diagnostic value of insulinlike growth factor II mRNA binding protein 3 (IMP3) on biliary cytology specimens.
METHODS
We selected 40 patients who had undergone a biliary cytology examination and whose diagnoses were confirmed by biopsy. The IMP3 expression was evaluated by immunohistochemical staining in both the tissue and the cytology specimens. Their histologic diagnoses were cholangiocarcinoma (n = 34), high grade dysplasia (n = 2), low grade dysplasia (n = 1) and non-biliary tumor or no tumor (n = 3).
RESULTS
On the histology, all the cases of cholangiocarcinoma or high grade dysplasia were positive for IMP3 (36/36). The low grade dysplasia or the normal bile ducts in the other 4 cases were negative for IMP3 (0/4). Of the 36 cases diagnosed as cholangiocarcinoma or high grade dysplasia histologically, 29 cases were positive for IMP3 on the cytology (29/36; sensitivity, 80.6%). Of the 4 cases without cholangiocarcinoma or high grade dysplasia, 1 case was weakly positive for IMP3 on the cytology. The histologic diagnosis of this case was hepatocellular carcinoma. Except for this hepatocellular carcinoma case, the specificity of IMP3 on the cytology was 100%.
CONCLUSIONS
IMP3 is a useful diagnostic marker for cholangiocarcinoma on cytology.

Keyword

IMP-3 protein, human; Cholangiocarcinoma; Cytology

MeSH Terms

Bile Ducts
Biopsy
Carcinoma, Hepatocellular
Carrier Proteins
Cholangiocarcinoma
Humans
Prothrombin
RNA, Messenger
RNA-Binding Proteins
Sensitivity and Specificity
Carrier Proteins
Prothrombin
RNA, Messenger
RNA-Binding Proteins
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr